hello world
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.
Stocks in play: Microbix Biosystems Inc.
Announces that key opinion leader collaborators are presenting results of a Microbix Quality Assessment Product for controlling testing for high-risk types of Human Papilloma Virus at the 36th annual International Papillomavirus Conference taking place in Edinburgh, Scotland, November 12 to 15. Microbix Biosystems Inc. shares T.MBX are trading unchanged at $0.32.
